Ticker
TRVICompany Name
TREVI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 117.06M | 12.67 | $ 9.24M |
3/31/2025 | $ 19.37M | 2.82 | $ 6.87M |
12/31/2024 | $ 34.1M | 3.24 | $ 10.51M |
9/30/2024 | $ 16.05M | 1.76 | $ 9.12M |
6/30/2024 | $ 12.96M | 1.92 | $ 6.75M |
3/31/2024 | $ 13.81M | 2.62 | $ 5.28M |
12/31/2023 | $ 32.4M | 5.56 | $ 5.82M |
9/30/2023 | $ 25.96M | 5.02 | $ 5.17M |
6/30/2023 | $ 13.75M | 2.92 | $ 4.71M |
3/31/2023 | $ 11.65M | 0.88 | $ 13.2M |
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for TREVI THERAPEUTICS INC is calculated as follows: CashnEq [ $ 53.29M ] / LiabilitesC [ $ 6.1M ]
(=) Cash Ratio [ 8.73 ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |